Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 11:44:01 2024-04-26 am EDT			After market 02:13:29 pm
37.42 ^EUR	-0.98%		37.5	+0.21%

09:02am	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies	ZD
Apr. 24	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

November 18, 2019 at 03:50 am EST

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
18.11.2019 / 09:48
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

- Share buy-back - 22^nd Interim Report

In the period from November 11, 2019 until and including November 15, 2019, a total of 174,687 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:

Day of repurchase	Aggregated volume in number of shares	Weighted average share price in EUR
11.11.2019	35,000	67.3409
12.11.2019	35,000	66.7128
13.11.2019	35,000	65.8681
14.11.2019	34,687	65.8113
15.11.2019	35,000	65.7392

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including November 15, 2019 therefore amounts to 4,078,422 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., November 18, 2019

18.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com


End of News	DGAP News Service

914937 18.11.2019

Latest news about Fresenius Medical Care AG

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies	03:02am	ZD
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 24	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research reiterates its Sell rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs keeps its Buy rating	Apr. 23	ZD
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	Apr. 22	MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	Apr. 22	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : DZ Bank sticks Neutral	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from Jefferies	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays gives a Neutral rating	Apr. 22	ZD
Berenberg rates FMC at 'Buy' - Target 47 euros	Apr. 22	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Buy rating from Berenberg	Apr. 22	ZD
Positive trend of FMC and Fresenius continues	Apr. 22	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reiterates its Sell rating	Apr. 19	ZD
STOXX 600 nears six-week low on geopolitical jitters; Ericsson shines	Apr. 16	RE
Fresenius at a two-month high - Tyenne launch and fantasy figures	Apr. 16	DP
Fresenius at two-month high - Tyenne launch a milestone	Apr. 16	DP
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	Apr. 15	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan gives a Sell rating	Apr. 04	ZD
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	Mar. 21	MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT
Fresenius Medical Care Launches Augmented Reality for Training on Kidney Replacement Therapy Device	Mar. 19	CI
Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar	Mar. 18	MT
Fresenius Settles With Johnson & Johnson to Market Stelara Alternative	Mar. 18	DJ
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading	Mar. 15	MT

Chart Fresenius Medical Care AG

Duration

Period

More charts

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

2024-05-06 - Q1 2024 Earnings Call

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Barebone 2023 profitability is a much lower starting point

February 21, 2024 at 04:12 am EST

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

37.79 EUR

Average target price

39.01 EUR

Spread / Average Target

+3.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	-1.42%	11.88B
CVS HEALTH CORPORATION	-14.89%	84.87B
HCA HEALTHCARE, INC.	+12.73%	83.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.79%	16.72B
FRESENIUS SE & CO. KGAA	-3.06%	16.4B
QUEST DIAGNOSTICS INCORPORATED	-2.06%	15.04B
EUROFINS SCIENTIFIC SE	-3.97%	11.88B
PURE HEALTH HOLDING	-31.75%	11.86B
DAVITA INC.	+26.73%	11.64B

Other Healthcare Facilities & Services